Case Study
Averaging 170% Enrollment Across Three Type 1 Diabetes Sites
Across three Texas sites, Tekton delivered consistent enrollment and regulatory performance for a Type 1 diabetes trial. All three sites exceeded their targets. Physician-led database review and detailed prescreening helped the McKinney site move quickly while focusing outreach on participants likely to meet the study requirements.
- All three sites exceeded enrollment targets
- 170% average enrollment across three sites
- 1-day average regulatory turnaround across three sites
- McKinney enrolled more than 200% of its initial goal and moved from activation to first participant visit in 4 days
About This Study
CLIENT
Large pharmaceutical company
TRIAL
Type 1 diabetes
TEKTON COVERAGE
Three sites in Irving, McKinney, and San Antonio, TX